nodes	percent_of_prediction	percent_of_DWPC	metapath
Telaprevir—ABCB1—Progesterone—uterine cancer	0.0965	0.222	CbGbCtD
Telaprevir—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0873	0.201	CbGbCtD
Telaprevir—ABCB1—Dactinomycin—uterine cancer	0.0765	0.176	CbGbCtD
Telaprevir—CYP3A4—Progesterone—uterine cancer	0.0578	0.133	CbGbCtD
Telaprevir—ABCB1—Etoposide—uterine cancer	0.0432	0.0994	CbGbCtD
Telaprevir—ABCB1—Doxorubicin—uterine cancer	0.0295	0.0678	CbGbCtD
Telaprevir—CMA1—artery—uterine cancer	0.0287	0.123	CbGeAlD
Telaprevir—CYP3A4—Etoposide—uterine cancer	0.0259	0.0596	CbGbCtD
Telaprevir—CYP3A4—Doxorubicin—uterine cancer	0.0177	0.0406	CbGbCtD
Telaprevir—CTSS—exocrine gland—uterine cancer	0.0141	0.0607	CbGeAlD
Telaprevir—Proctitis—Dactinomycin—uterine cancer	0.0118	0.0451	CcSEcCtD
Telaprevir—CMA1—smooth muscle tissue—uterine cancer	0.0105	0.0451	CbGeAlD
Telaprevir—Pruritus genital—Progesterone—uterine cancer	0.00976	0.0373	CcSEcCtD
Telaprevir—CMA1—mammalian vulva—uterine cancer	0.00945	0.0406	CbGeAlD
Telaprevir—CTSK—myometrium—uterine cancer	0.00895	0.0384	CbGeAlD
Telaprevir—CMA1—female reproductive system—uterine cancer	0.00809	0.0347	CbGeAlD
Telaprevir—CTSS—myometrium—uterine cancer	0.00784	0.0336	CbGeAlD
Telaprevir—Pregnancy—Progesterone—uterine cancer	0.00718	0.0274	CcSEcCtD
Telaprevir—CTSK—uterine cervix—uterine cancer	0.00696	0.0299	CbGeAlD
Telaprevir—CTSK—smooth muscle tissue—uterine cancer	0.00677	0.029	CbGeAlD
Telaprevir—CTSK—decidua—uterine cancer	0.00663	0.0285	CbGeAlD
Telaprevir—CTSK—renal system—uterine cancer	0.00651	0.028	CbGeAlD
Telaprevir—Pregnancy—Medroxyprogesterone Acetate—uterine cancer	0.00651	0.0249	CcSEcCtD
Telaprevir—CTSK—endometrium—uterine cancer	0.0063	0.027	CbGeAlD
Telaprevir—CTSS—uterine cervix—uterine cancer	0.0061	0.0262	CbGeAlD
Telaprevir—CTSK—mammalian vulva—uterine cancer	0.00609	0.0261	CbGeAlD
Telaprevir—CTSS—smooth muscle tissue—uterine cancer	0.00593	0.0254	CbGeAlD
Telaprevir—CTSS—decidua—uterine cancer	0.00581	0.0249	CbGeAlD
Telaprevir—CTSK—uterus—uterine cancer	0.0058	0.0249	CbGeAlD
Telaprevir—Hypothyroidism—Medroxyprogesterone Acetate—uterine cancer	0.00575	0.022	CcSEcCtD
Telaprevir—CTSS—renal system—uterine cancer	0.00571	0.0245	CbGeAlD
Telaprevir—CTSS—endometrium—uterine cancer	0.00552	0.0237	CbGeAlD
Telaprevir—CTSS—mammalian vulva—uterine cancer	0.00534	0.0229	CbGeAlD
Telaprevir—CTSK—female reproductive system—uterine cancer	0.00522	0.0224	CbGeAlD
Telaprevir—CTSS—uterus—uterine cancer	0.00508	0.0218	CbGeAlD
Telaprevir—Endocrine disorder—Progesterone—uterine cancer	0.00492	0.0188	CcSEcCtD
Telaprevir—Proctitis—Epirubicin—uterine cancer	0.00479	0.0183	CcSEcCtD
Telaprevir—CTSK—female gonad—uterine cancer	0.00475	0.0204	CbGeAlD
Telaprevir—CMA1—lymph node—uterine cancer	0.00474	0.0203	CbGeAlD
Telaprevir—CTSK—vagina—uterine cancer	0.00472	0.0202	CbGeAlD
Telaprevir—CTSS—female reproductive system—uterine cancer	0.00457	0.0196	CbGeAlD
Telaprevir—Endocrine disorder—Medroxyprogesterone Acetate—uterine cancer	0.00446	0.017	CcSEcCtD
Telaprevir—Proctitis—Doxorubicin—uterine cancer	0.00443	0.0169	CcSEcCtD
Telaprevir—CTSS—female gonad—uterine cancer	0.00416	0.0179	CbGeAlD
Telaprevir—CTSS—vagina—uterine cancer	0.00413	0.0177	CbGeAlD
Telaprevir—Rectal haemorrhage—Medroxyprogesterone Acetate—uterine cancer	0.00409	0.0156	CcSEcCtD
Telaprevir—Anorectal discomfort—Etoposide—uterine cancer	0.00381	0.0146	CcSEcCtD
Telaprevir—ORM1—endometrium—uterine cancer	0.00329	0.0141	CbGeAlD
Telaprevir—CTSK—lymph node—uterine cancer	0.00305	0.0131	CbGeAlD
Telaprevir—Infection—Carboplatin—uterine cancer	0.00275	0.0105	CcSEcCtD
Telaprevir—ORM1—female reproductive system—uterine cancer	0.00273	0.0117	CbGeAlD
Telaprevir—CTSS—lymph node—uterine cancer	0.00267	0.0115	CbGeAlD
Telaprevir—Blood creatinine increased—Medroxyprogesterone Acetate—uterine cancer	0.00251	0.00959	CcSEcCtD
Telaprevir—Proctalgia—Epirubicin—uterine cancer	0.00249	0.00952	CcSEcCtD
Telaprevir—Hypokalaemia—Medroxyprogesterone Acetate—uterine cancer	0.00244	0.00932	CcSEcCtD
Telaprevir—Proctalgia—Doxorubicin—uterine cancer	0.00231	0.00881	CcSEcCtD
Telaprevir—Lymphopenia—Epirubicin—uterine cancer	0.00228	0.00872	CcSEcCtD
Telaprevir—Infestation NOS—Progesterone—uterine cancer	0.00228	0.00871	CcSEcCtD
Telaprevir—Infestation—Progesterone—uterine cancer	0.00228	0.00871	CcSEcCtD
Telaprevir—Hyperuricaemia—Etoposide—uterine cancer	0.00225	0.00859	CcSEcCtD
Telaprevir—Hepatobiliary disease—Progesterone—uterine cancer	0.00216	0.00824	CcSEcCtD
Telaprevir—Anorectal discomfort—Epirubicin—uterine cancer	0.00214	0.00817	CcSEcCtD
Telaprevir—Blood uric acid increased—Etoposide—uterine cancer	0.00212	0.00811	CcSEcCtD
Telaprevir—Lymphopenia—Doxorubicin—uterine cancer	0.00211	0.00807	CcSEcCtD
Telaprevir—Infestation NOS—Medroxyprogesterone Acetate—uterine cancer	0.00207	0.00789	CcSEcCtD
Telaprevir—Infestation—Medroxyprogesterone Acetate—uterine cancer	0.00207	0.00789	CcSEcCtD
Telaprevir—Urinary tract disorder—Progesterone—uterine cancer	0.00202	0.00772	CcSEcCtD
Telaprevir—Oedema peripheral—Progesterone—uterine cancer	0.00202	0.0077	CcSEcCtD
Telaprevir—Urethral disorder—Progesterone—uterine cancer	0.00201	0.00766	CcSEcCtD
Telaprevir—Candida infection—Etoposide—uterine cancer	0.00199	0.0076	CcSEcCtD
Telaprevir—Anorectal discomfort—Doxorubicin—uterine cancer	0.00198	0.00756	CcSEcCtD
Telaprevir—Hepatobiliary disease—Medroxyprogesterone Acetate—uterine cancer	0.00195	0.00746	CcSEcCtD
Telaprevir—Erythema multiforme—Progesterone—uterine cancer	0.00194	0.00739	CcSEcCtD
Telaprevir—Eye disorder—Progesterone—uterine cancer	0.00191	0.00731	CcSEcCtD
Telaprevir—Toxic epidermal necrolysis—Dactinomycin—uterine cancer	0.00188	0.00719	CcSEcCtD
Telaprevir—Oral candidiasis—Epirubicin—uterine cancer	0.00184	0.00703	CcSEcCtD
Telaprevir—Urinary tract disorder—Medroxyprogesterone Acetate—uterine cancer	0.00183	0.007	CcSEcCtD
Telaprevir—Oedema peripheral—Medroxyprogesterone Acetate—uterine cancer	0.00183	0.00698	CcSEcCtD
Telaprevir—Urethral disorder—Medroxyprogesterone Acetate—uterine cancer	0.00182	0.00695	CcSEcCtD
Telaprevir—Malnutrition—Progesterone—uterine cancer	0.00178	0.00681	CcSEcCtD
Telaprevir—Erythema multiforme—Medroxyprogesterone Acetate—uterine cancer	0.00175	0.0067	CcSEcCtD
Telaprevir—Eye disorder—Medroxyprogesterone Acetate—uterine cancer	0.00173	0.00662	CcSEcCtD
Telaprevir—Oral candidiasis—Doxorubicin—uterine cancer	0.0017	0.0065	CcSEcCtD
Telaprevir—Anaemia—Progesterone—uterine cancer	0.00165	0.00629	CcSEcCtD
Telaprevir—Malnutrition—Medroxyprogesterone Acetate—uterine cancer	0.00161	0.00617	CcSEcCtD
Telaprevir—Syncope—Progesterone—uterine cancer	0.0016	0.0061	CcSEcCtD
Telaprevir—Stevens-Johnson syndrome—Dactinomycin—uterine cancer	0.0016	0.0061	CcSEcCtD
Telaprevir—ORM1—lymph node—uterine cancer	0.0016	0.00685	CbGeAlD
Telaprevir—Dysgeusia—Medroxyprogesterone Acetate—uterine cancer	0.00158	0.00604	CcSEcCtD
Telaprevir—Loss of consciousness—Progesterone—uterine cancer	0.00157	0.00598	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Progesterone—uterine cancer	0.00151	0.00575	CcSEcCtD
Telaprevir—Anaemia—Medroxyprogesterone Acetate—uterine cancer	0.00149	0.0057	CcSEcCtD
Telaprevir—Syncope—Medroxyprogesterone Acetate—uterine cancer	0.00145	0.00553	CcSEcCtD
Telaprevir—Infection—Progesterone—uterine cancer	0.00144	0.00552	CcSEcCtD
Telaprevir—Shock—Progesterone—uterine cancer	0.00143	0.00547	CcSEcCtD
Telaprevir—Nervous system disorder—Progesterone—uterine cancer	0.00143	0.00545	CcSEcCtD
Telaprevir—CYP3A4—renal system—uterine cancer	0.00142	0.00611	CbGeAlD
Telaprevir—Loss of consciousness—Medroxyprogesterone Acetate—uterine cancer	0.00142	0.00542	CcSEcCtD
Telaprevir—Skin disorder—Progesterone—uterine cancer	0.00141	0.0054	CcSEcCtD
Telaprevir—ALB—lymph node—uterine cancer	0.0014	0.00601	CbGeAlD
Telaprevir—ABCB1—myometrium—uterine cancer	0.00138	0.00594	CbGeAlD
Telaprevir—Erythema multiforme—Dactinomycin—uterine cancer	0.00137	0.00523	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.00137	0.00521	CcSEcCtD
Telaprevir—Toxic epidermal necrolysis—Etoposide—uterine cancer	0.00136	0.00521	CcSEcCtD
Telaprevir—Infection—Medroxyprogesterone Acetate—uterine cancer	0.00131	0.005	CcSEcCtD
Telaprevir—Shock—Medroxyprogesterone Acetate—uterine cancer	0.0013	0.00495	CcSEcCtD
Telaprevir—Rectal haemorrhage—Epirubicin—uterine cancer	0.00129	0.00494	CcSEcCtD
Telaprevir—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.00129	0.00494	CcSEcCtD
Telaprevir—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.00129	0.00493	CcSEcCtD
Telaprevir—Hyperbilirubinaemia—Epirubicin—uterine cancer	0.00129	0.00491	CcSEcCtD
Telaprevir—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.00128	0.00489	CcSEcCtD
Telaprevir—Hyperuricaemia—Epirubicin—uterine cancer	0.00126	0.00481	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Progesterone—uterine cancer	0.00126	0.0048	CcSEcCtD
Telaprevir—Fatigue—Progesterone—uterine cancer	0.00125	0.00479	CcSEcCtD
Telaprevir—Rectal haemorrhage—Doxorubicin—uterine cancer	0.0012	0.00457	CcSEcCtD
Telaprevir—Blood uric acid increased—Epirubicin—uterine cancer	0.00119	0.00455	CcSEcCtD
Telaprevir—Hyperbilirubinaemia—Doxorubicin—uterine cancer	0.00119	0.00454	CcSEcCtD
Telaprevir—Infestation—Etoposide—uterine cancer	0.00117	0.00446	CcSEcCtD
Telaprevir—Infestation NOS—Etoposide—uterine cancer	0.00117	0.00446	CcSEcCtD
Telaprevir—Hyperuricaemia—Doxorubicin—uterine cancer	0.00117	0.00445	CcSEcCtD
Telaprevir—Anaemia—Dactinomycin—uterine cancer	0.00116	0.00445	CcSEcCtD
Telaprevir—Stevens-Johnson syndrome—Etoposide—uterine cancer	0.00116	0.00442	CcSEcCtD
Telaprevir—Urticaria—Progesterone—uterine cancer	0.00116	0.00441	CcSEcCtD
Telaprevir—CYP3A4—female reproductive system—uterine cancer	0.00114	0.00489	CbGeAlD
Telaprevir—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00114	0.00435	CcSEcCtD
Telaprevir—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.00114	0.00434	CcSEcCtD
Telaprevir—Candida infection—Epirubicin—uterine cancer	0.00112	0.00426	CcSEcCtD
Telaprevir—Hepatobiliary disease—Etoposide—uterine cancer	0.0011	0.00421	CcSEcCtD
Telaprevir—Blood uric acid increased—Doxorubicin—uterine cancer	0.0011	0.00421	CcSEcCtD
Telaprevir—ABCB1—epithelium—uterine cancer	0.00109	0.00466	CbGeAlD
Telaprevir—ABCB1—uterine cervix—uterine cancer	0.00108	0.00462	CbGeAlD
Telaprevir—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00105	0.004	CcSEcCtD
Telaprevir—Asthenia—Progesterone—uterine cancer	0.00104	0.00399	CcSEcCtD
Telaprevir—Urinary tract disorder—Etoposide—uterine cancer	0.00103	0.00395	CcSEcCtD
Telaprevir—Candida infection—Doxorubicin—uterine cancer	0.00103	0.00394	CcSEcCtD
Telaprevir—Pruritus—Progesterone—uterine cancer	0.00103	0.00393	CcSEcCtD
Telaprevir—Urethral disorder—Etoposide—uterine cancer	0.00103	0.00392	CcSEcCtD
Telaprevir—ABCB1—decidua—uterine cancer	0.00103	0.0044	CbGeAlD
Telaprevir—Infection—Dactinomycin—uterine cancer	0.00102	0.0039	CcSEcCtD
Telaprevir—ABCB1—renal system—uterine cancer	0.00101	0.00432	CbGeAlD
Telaprevir—Thrombocytopenia—Dactinomycin—uterine cancer	0.00101	0.00384	CcSEcCtD
Telaprevir—Diarrhoea—Progesterone—uterine cancer	0.000995	0.0038	CcSEcCtD
Telaprevir—Erythema multiforme—Etoposide—uterine cancer	0.00099	0.00378	CcSEcCtD
Telaprevir—Eye disorder—Etoposide—uterine cancer	0.000978	0.00374	CcSEcCtD
Telaprevir—ABCB1—endometrium—uterine cancer	0.000973	0.00418	CbGeAlD
Telaprevir—Dizziness—Progesterone—uterine cancer	0.000962	0.00367	CcSEcCtD
Telaprevir—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000945	0.00361	CcSEcCtD
Telaprevir—Eczema—Epirubicin—uterine cancer	0.000944	0.00361	CcSEcCtD
Telaprevir—ABCB1—mammalian vulva—uterine cancer	0.000942	0.00404	CbGeAlD
Telaprevir—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000932	0.00356	CcSEcCtD
Telaprevir—Vomiting—Progesterone—uterine cancer	0.000925	0.00353	CcSEcCtD
Telaprevir—Renal failure acute—Epirubicin—uterine cancer	0.000919	0.00351	CcSEcCtD
Telaprevir—Rash—Progesterone—uterine cancer	0.000917	0.0035	CcSEcCtD
Telaprevir—Dermatitis—Progesterone—uterine cancer	0.000916	0.0035	CcSEcCtD
Telaprevir—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000902	0.00344	CcSEcCtD
Telaprevir—ABCB1—uterus—uterine cancer	0.000897	0.00385	CbGeAlD
Telaprevir—Dysgeusia—Etoposide—uterine cancer	0.000893	0.00341	CcSEcCtD
Telaprevir—Fatigue—Dactinomycin—uterine cancer	0.000886	0.00339	CcSEcCtD
Telaprevir—Eczema—Doxorubicin—uterine cancer	0.000873	0.00334	CcSEcCtD
Telaprevir—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000871	0.00333	CcSEcCtD
Telaprevir—Nausea—Progesterone—uterine cancer	0.000864	0.0033	CcSEcCtD
Telaprevir—Renal failure acute—Doxorubicin—uterine cancer	0.00085	0.00325	CcSEcCtD
Telaprevir—Anaemia—Etoposide—uterine cancer	0.000842	0.00322	CcSEcCtD
Telaprevir—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000838	0.0032	CcSEcCtD
Telaprevir—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000831	0.00317	CcSEcCtD
Telaprevir—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00083	0.00317	CcSEcCtD
Telaprevir—ABCB1—female reproductive system—uterine cancer	0.000806	0.00346	CbGeAlD
Telaprevir—Loss of consciousness—Etoposide—uterine cancer	0.000801	0.00306	CcSEcCtD
Telaprevir—Blood creatinine increased—Epirubicin—uterine cancer	0.000795	0.00304	CcSEcCtD
Telaprevir—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000783	0.00299	CcSEcCtD
Telaprevir—Hypokalaemia—Epirubicin—uterine cancer	0.000772	0.00295	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000771	0.00294	CcSEcCtD
Telaprevir—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.000764	0.00292	CcSEcCtD
Telaprevir—Infection—Etoposide—uterine cancer	0.000739	0.00282	CcSEcCtD
Telaprevir—Asthenia—Dactinomycin—uterine cancer	0.000737	0.00282	CcSEcCtD
Telaprevir—Blood creatinine increased—Doxorubicin—uterine cancer	0.000735	0.00281	CcSEcCtD
Telaprevir—ABCB1—female gonad—uterine cancer	0.000734	0.00315	CbGeAlD
Telaprevir—ABCB1—vagina—uterine cancer	0.000729	0.00313	CbGeAlD
Telaprevir—Thrombocytopenia—Etoposide—uterine cancer	0.000728	0.00278	CcSEcCtD
Telaprevir—Eosinophilia—Epirubicin—uterine cancer	0.000726	0.00277	CcSEcCtD
Telaprevir—Skin disorder—Etoposide—uterine cancer	0.000723	0.00276	CcSEcCtD
Telaprevir—Hypokalaemia—Doxorubicin—uterine cancer	0.000714	0.00273	CcSEcCtD
Telaprevir—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.000707	0.0027	CcSEcCtD
Telaprevir—Diarrhoea—Dactinomycin—uterine cancer	0.000703	0.00269	CcSEcCtD
Telaprevir—Eosinophilia—Doxorubicin—uterine cancer	0.000672	0.00257	CcSEcCtD
Telaprevir—Infestation NOS—Epirubicin—uterine cancer	0.000654	0.0025	CcSEcCtD
Telaprevir—Infestation—Epirubicin—uterine cancer	0.000654	0.0025	CcSEcCtD
Telaprevir—Vomiting—Dactinomycin—uterine cancer	0.000653	0.0025	CcSEcCtD
Telaprevir—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000648	0.00248	CcSEcCtD
Telaprevir—Rash—Dactinomycin—uterine cancer	0.000648	0.00248	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Etoposide—uterine cancer	0.000642	0.00245	CcSEcCtD
Telaprevir—Fatigue—Etoposide—uterine cancer	0.000641	0.00245	CcSEcCtD
Telaprevir—Hepatobiliary disease—Epirubicin—uterine cancer	0.000618	0.00236	CcSEcCtD
Telaprevir—Nausea—Dactinomycin—uterine cancer	0.00061	0.00233	CcSEcCtD
Telaprevir—Infestation NOS—Doxorubicin—uterine cancer	0.000605	0.00231	CcSEcCtD
Telaprevir—Infestation—Doxorubicin—uterine cancer	0.000605	0.00231	CcSEcCtD
Telaprevir—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.0006	0.00229	CcSEcCtD
Telaprevir—Urticaria—Etoposide—uterine cancer	0.000591	0.00226	CcSEcCtD
Telaprevir—Urinary tract disorder—Epirubicin—uterine cancer	0.00058	0.00221	CcSEcCtD
Telaprevir—Oedema peripheral—Epirubicin—uterine cancer	0.000578	0.00221	CcSEcCtD
Telaprevir—Urethral disorder—Epirubicin—uterine cancer	0.000575	0.0022	CcSEcCtD
Telaprevir—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000572	0.00219	CcSEcCtD
Telaprevir—Erythema multiforme—Epirubicin—uterine cancer	0.000555	0.00212	CcSEcCtD
Telaprevir—CTSK—RANKL/RANK Signaling Pathway—AKT1—uterine cancer	0.000548	0.00774	CbGpPWpGaD
Telaprevir—Eye disorder—Epirubicin—uterine cancer	0.000548	0.0021	CcSEcCtD
Telaprevir—CMA1—Signaling by SCF-KIT—CDKN1B—uterine cancer	0.000546	0.0077	CbGpPWpGaD
Telaprevir—Urinary tract disorder—Doxorubicin—uterine cancer	0.000536	0.00205	CcSEcCtD
Telaprevir—Oedema peripheral—Doxorubicin—uterine cancer	0.000535	0.00204	CcSEcCtD
Telaprevir—Asthenia—Etoposide—uterine cancer	0.000534	0.00204	CcSEcCtD
Telaprevir—Urethral disorder—Doxorubicin—uterine cancer	0.000532	0.00203	CcSEcCtD
Telaprevir—Pruritus—Etoposide—uterine cancer	0.000526	0.00201	CcSEcCtD
Telaprevir—CTSS—Class I MHC mediated antigen processing & presentation—SOCS3—uterine cancer	0.000519	0.00733	CbGpPWpGaD
Telaprevir—Erythema multiforme—Doxorubicin—uterine cancer	0.000513	0.00196	CcSEcCtD
Telaprevir—Malnutrition—Epirubicin—uterine cancer	0.000511	0.00195	CcSEcCtD
Telaprevir—Diarrhoea—Etoposide—uterine cancer	0.000509	0.00194	CcSEcCtD
Telaprevir—Eye disorder—Doxorubicin—uterine cancer	0.000507	0.00194	CcSEcCtD
Telaprevir—CMA1—Signaling by SCF-KIT—PTEN—uterine cancer	0.000503	0.00709	CbGpPWpGaD
Telaprevir—Dysgeusia—Epirubicin—uterine cancer	0.0005	0.00191	CcSEcCtD
Telaprevir—Dizziness—Etoposide—uterine cancer	0.000492	0.00188	CcSEcCtD
Telaprevir—Vomiting—Etoposide—uterine cancer	0.000473	0.00181	CcSEcCtD
Telaprevir—Malnutrition—Doxorubicin—uterine cancer	0.000473	0.00181	CcSEcCtD
Telaprevir—Anaemia—Epirubicin—uterine cancer	0.000472	0.0018	CcSEcCtD
Telaprevir—ABCB1—lymph node—uterine cancer	0.000472	0.00202	CbGeAlD
Telaprevir—Rash—Etoposide—uterine cancer	0.000469	0.00179	CcSEcCtD
Telaprevir—Dermatitis—Etoposide—uterine cancer	0.000469	0.00179	CcSEcCtD
Telaprevir—Dysgeusia—Doxorubicin—uterine cancer	0.000463	0.00177	CcSEcCtD
Telaprevir—Syncope—Epirubicin—uterine cancer	0.000458	0.00175	CcSEcCtD
Telaprevir—Loss of consciousness—Epirubicin—uterine cancer	0.000449	0.00172	CcSEcCtD
Telaprevir—CMA1—Signaling by SCF-KIT—NRAS—uterine cancer	0.000449	0.00633	CbGpPWpGaD
Telaprevir—ALB—Folate Metabolism—GPX3—uterine cancer	0.000446	0.0063	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—IRF1—uterine cancer	0.000443	0.00626	CbGpPWpGaD
Telaprevir—Nausea—Etoposide—uterine cancer	0.000442	0.00169	CcSEcCtD
Telaprevir—Anaemia—Doxorubicin—uterine cancer	0.000437	0.00167	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000432	0.00165	CcSEcCtD
Telaprevir—Syncope—Doxorubicin—uterine cancer	0.000424	0.00162	CcSEcCtD
Telaprevir—CMA1—Extracellular matrix organization—CDH1—uterine cancer	0.000423	0.00597	CbGpPWpGaD
Telaprevir—Loss of consciousness—Doxorubicin—uterine cancer	0.000415	0.00159	CcSEcCtD
Telaprevir—Infection—Epirubicin—uterine cancer	0.000414	0.00158	CcSEcCtD
Telaprevir—Shock—Epirubicin—uterine cancer	0.00041	0.00157	CcSEcCtD
Telaprevir—Nervous system disorder—Epirubicin—uterine cancer	0.000409	0.00156	CcSEcCtD
Telaprevir—Thrombocytopenia—Epirubicin—uterine cancer	0.000408	0.00156	CcSEcCtD
Telaprevir—Skin disorder—Epirubicin—uterine cancer	0.000405	0.00155	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.0004	0.00153	CcSEcCtD
Telaprevir—CMA1—Metabolism of proteins—FBXW7—uterine cancer	0.000389	0.0055	CbGpPWpGaD
Telaprevir—CMA1—Signaling by SCF-KIT—KRAS—uterine cancer	0.000386	0.00545	CbGpPWpGaD
Telaprevir—Infection—Doxorubicin—uterine cancer	0.000383	0.00146	CcSEcCtD
Telaprevir—CTSK—Adaptive Immune System—FBXW7—uterine cancer	0.000381	0.00538	CbGpPWpGaD
Telaprevir—Shock—Doxorubicin—uterine cancer	0.00038	0.00145	CcSEcCtD
Telaprevir—Nervous system disorder—Doxorubicin—uterine cancer	0.000378	0.00145	CcSEcCtD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MAP3K4—uterine cancer	0.000378	0.00534	CbGpPWpGaD
Telaprevir—Thrombocytopenia—Doxorubicin—uterine cancer	0.000378	0.00144	CcSEcCtD
Telaprevir—CTSK—Extracellular matrix organization—CDH1—uterine cancer	0.000377	0.00532	CbGpPWpGaD
Telaprevir—Skin disorder—Doxorubicin—uterine cancer	0.000375	0.00143	CcSEcCtD
Telaprevir—CTSS—Innate Immune System—IRF1—uterine cancer	0.000365	0.00515	CbGpPWpGaD
Telaprevir—Gastrointestinal disorder—Epirubicin—uterine cancer	0.00036	0.00138	CcSEcCtD
Telaprevir—Fatigue—Epirubicin—uterine cancer	0.000359	0.00137	CcSEcCtD
Telaprevir—CMA1—Signaling Pathways—AKR1B10—uterine cancer	0.000358	0.00506	CbGpPWpGaD
Telaprevir—CMA1—Signaling by SCF-KIT—PIK3CA—uterine cancer	0.000355	0.005	CbGpPWpGaD
Telaprevir—ALB—Selenium Micronutrient Network—GPX3—uterine cancer	0.000354	0.005	CbGpPWpGaD
Telaprevir—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000333	0.00127	CcSEcCtD
Telaprevir—Fatigue—Doxorubicin—uterine cancer	0.000333	0.00127	CcSEcCtD
Telaprevir—Urticaria—Epirubicin—uterine cancer	0.000331	0.00127	CcSEcCtD
Telaprevir—CMA1—Signaling by SCF-KIT—HRAS—uterine cancer	0.000328	0.00463	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—FBXW7—uterine cancer	0.000314	0.00443	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—SOCS3—uterine cancer	0.000312	0.00441	CbGpPWpGaD
Telaprevir—CTSS—Extracellular matrix organization—CDH1—uterine cancer	0.000311	0.00438	CbGpPWpGaD
Telaprevir—Urticaria—Doxorubicin—uterine cancer	0.000306	0.00117	CcSEcCtD
Telaprevir—Asthenia—Epirubicin—uterine cancer	0.000299	0.00114	CcSEcCtD
Telaprevir—CMA1—Signaling Pathways—RNF43—uterine cancer	0.000297	0.00419	CbGpPWpGaD
Telaprevir—Pruritus—Epirubicin—uterine cancer	0.000295	0.00113	CcSEcCtD
Telaprevir—CMA1—Signaling by SCF-KIT—AKT1—uterine cancer	0.00029	0.00409	CbGpPWpGaD
Telaprevir—Diarrhoea—Epirubicin—uterine cancer	0.000285	0.00109	CcSEcCtD
Telaprevir—ALB—Vitamin B12 Metabolism—MTHFR—uterine cancer	0.000282	0.00397	CbGpPWpGaD
Telaprevir—Asthenia—Doxorubicin—uterine cancer	0.000277	0.00106	CcSEcCtD
Telaprevir—Dizziness—Epirubicin—uterine cancer	0.000276	0.00105	CcSEcCtD
Telaprevir—Pruritus—Doxorubicin—uterine cancer	0.000273	0.00104	CcSEcCtD
Telaprevir—CMA1—Signaling Pathways—INHBA—uterine cancer	0.000272	0.00383	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—FGFR2—uterine cancer	0.000271	0.00382	CbGpPWpGaD
Telaprevir—Vomiting—Epirubicin—uterine cancer	0.000265	0.00101	CcSEcCtD
Telaprevir—Diarrhoea—Doxorubicin—uterine cancer	0.000264	0.00101	CcSEcCtD
Telaprevir—Rash—Epirubicin—uterine cancer	0.000263	0.001	CcSEcCtD
Telaprevir—Dermatitis—Epirubicin—uterine cancer	0.000263	0.001	CcSEcCtD
Telaprevir—CTSK—Adaptive Immune System—FGFR2—uterine cancer	0.00026	0.00367	CbGpPWpGaD
Telaprevir—CTSK—Immune System—IRF1—uterine cancer	0.000258	0.00364	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—SOCS3—uterine cancer	0.000257	0.00363	CbGpPWpGaD
Telaprevir—Dizziness—Doxorubicin—uterine cancer	0.000255	0.000975	CcSEcCtD
Telaprevir—Nausea—Epirubicin—uterine cancer	0.000248	0.000946	CcSEcCtD
Telaprevir—Vomiting—Doxorubicin—uterine cancer	0.000245	0.000937	CcSEcCtD
Telaprevir—CMA1—Signaling Pathways—AKR1C1—uterine cancer	0.000245	0.00345	CbGpPWpGaD
Telaprevir—Rash—Doxorubicin—uterine cancer	0.000243	0.000929	CcSEcCtD
Telaprevir—Dermatitis—Doxorubicin—uterine cancer	0.000243	0.000928	CcSEcCtD
Telaprevir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000241	0.00341	CbGpPWpGaD
Telaprevir—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000238	0.00336	CbGpPWpGaD
Telaprevir—CTSK—Immune System—FBXW7—uterine cancer	0.000231	0.00326	CbGpPWpGaD
Telaprevir—Nausea—Doxorubicin—uterine cancer	0.000229	0.000875	CcSEcCtD
Telaprevir—ALB—Folate Metabolism—MTHFR—uterine cancer	0.000229	0.00323	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—FGFR2—uterine cancer	0.000223	0.00315	CbGpPWpGaD
Telaprevir—ALB—Vitamin B12 Metabolism—CCL2—uterine cancer	0.00022	0.00311	CbGpPWpGaD
Telaprevir—CYP3A4—Tryptophan metabolism—CYP19A1—uterine cancer	0.00022	0.0031	CbGpPWpGaD
Telaprevir—ABCB1—HIF-1-alpha transcription factor network—SMAD3—uterine cancer	0.000219	0.00308	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—FGFR2—uterine cancer	0.000214	0.00302	CbGpPWpGaD
Telaprevir—CTSS—Immune System—IRF1—uterine cancer	0.000213	0.003	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—INHBA—uterine cancer	0.000211	0.00298	CbGpPWpGaD
Telaprevir—CMA1—Metabolism of proteins—CCL2—uterine cancer	0.0002	0.00282	CbGpPWpGaD
Telaprevir—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000196	0.00276	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—CDH1—uterine cancer	0.000194	0.00273	CbGpPWpGaD
Telaprevir—CTSS—Immune System—FBXW7—uterine cancer	0.000191	0.00269	CbGpPWpGaD
Telaprevir—CTSK—Immune System—SOCS3—uterine cancer	0.000189	0.00267	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—AKR1C3—uterine cancer	0.000188	0.00266	CbGpPWpGaD
Telaprevir—CYP3A4—Metapathway biotransformation—AKR1B10—uterine cancer	0.000184	0.0026	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—PGR—uterine cancer	0.000184	0.00259	CbGpPWpGaD
Telaprevir—ALB—Selenium Micronutrient Network—MTHFR—uterine cancer	0.000182	0.00257	CbGpPWpGaD
Telaprevir—ALB—Folate Metabolism—CCL2—uterine cancer	0.000179	0.00253	CbGpPWpGaD
Telaprevir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000178	0.00251	CbGpPWpGaD
Telaprevir—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000175	0.00247	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—YWHAE—uterine cancer	0.000175	0.00247	CbGpPWpGaD
Telaprevir—CYP3A4—Metapathway biotransformation—AKR1B1—uterine cancer	0.000171	0.00242	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.000171	0.00241	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—ERBB2—uterine cancer	0.00017	0.0024	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—FBXW7—uterine cancer	0.000168	0.00237	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—ERBB2—uterine cancer	0.000163	0.00231	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—CDH1—uterine cancer	0.00016	0.00225	CbGpPWpGaD
Telaprevir—CMA1—Metabolism of proteins—CXCL8—uterine cancer	0.000158	0.00223	CbGpPWpGaD
Telaprevir—CTSK—Immune System—FGFR2—uterine cancer	0.000158	0.00223	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—CDKN1B—uterine cancer	0.000158	0.00222	CbGpPWpGaD
Telaprevir—CTSS—Immune System—SOCS3—uterine cancer	0.000156	0.0022	CbGpPWpGaD
Telaprevir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—uterine cancer	0.000154	0.00217	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—CDKN1B—uterine cancer	0.000151	0.00214	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—CTNNB1—uterine cancer	0.000149	0.0021	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—STK11—uterine cancer	0.000147	0.00207	CbGpPWpGaD
Telaprevir—CMA1—Metabolism of proteins—CTNNB1—uterine cancer	0.000146	0.00206	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—PTEN—uterine cancer	0.000145	0.00205	CbGpPWpGaD
Telaprevir—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000144	0.00203	CbGpPWpGaD
Telaprevir—ALB—Selenium Micronutrient Network—CCL2—uterine cancer	0.000142	0.00201	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—ERBB2—uterine cancer	0.00014	0.00198	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—PTEN—uterine cancer	0.000139	0.00197	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—EP300—uterine cancer	0.000138	0.00195	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—SOCS3—uterine cancer	0.000137	0.00194	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	0.000136	0.00191	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—ERBB2—uterine cancer	0.000135	0.0019	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—CDKN2B—uterine cancer	0.000132	0.00186	CbGpPWpGaD
Telaprevir—CTSS—Immune System—FGFR2—uterine cancer	0.00013	0.00183	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—CDKN1B—uterine cancer	0.00013	0.00183	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—NRAS—uterine cancer	0.00013	0.00183	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—IGF1R—uterine cancer	0.000128	0.0018	CbGpPWpGaD
Telaprevir—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	0.000126	0.00177	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	0.000126	0.00177	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—CDKN1B—uterine cancer	0.000125	0.00176	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—NRAS—uterine cancer	0.000124	0.00175	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.000124	0.00174	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.000124	0.00174	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—CTNNB1—uterine cancer	0.000123	0.00173	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—SMAD3—uterine cancer	0.00012	0.00169	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—PTEN—uterine cancer	0.00012	0.00169	CbGpPWpGaD
Telaprevir—CTSK—Immune System—CDH1—uterine cancer	0.000118	0.00166	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000117	0.00166	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—PTEN—uterine cancer	0.000115	0.00162	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—FGFR2—uterine cancer	0.000115	0.00162	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	0.000114	0.00161	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—EP300—uterine cancer	0.000114	0.00161	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—KRAS—uterine cancer	0.000111	0.00157	CbGpPWpGaD
Telaprevir—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	0.00011	0.00156	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—CXCL8—uterine cancer	0.000108	0.00152	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—KRAS—uterine cancer	0.000107	0.00151	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—NRAS—uterine cancer	0.000107	0.0015	CbGpPWpGaD
Telaprevir—ABCB1—HIF-1-alpha transcription factor network—EP300—uterine cancer	0.000106	0.0015	CbGpPWpGaD
Telaprevir—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	0.000104	0.00147	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000103	0.00145	CbGpPWpGaD
Telaprevir—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	0.000103	0.00145	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—NRAS—uterine cancer	0.000102	0.00145	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—PIK3CA—uterine cancer	0.000102	0.00144	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	0.000102	0.00144	CbGpPWpGaD
Telaprevir—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—uterine cancer	0.000102	0.00143	CbGpPWpGaD
Telaprevir—ABCB1—HIF-1-alpha transcription factor network—VEGFA—uterine cancer	0.000101	0.00142	CbGpPWpGaD
Telaprevir—CTSK—Immune System—ERBB2—uterine cancer	9.91e-05	0.0014	CbGpPWpGaD
Telaprevir—ALB—Platelet degranulation—VEGFA—uterine cancer	9.87e-05	0.00139	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—PIK3CA—uterine cancer	9.83e-05	0.00139	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—ESR1—uterine cancer	9.8e-05	0.00138	CbGpPWpGaD
Telaprevir—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	9.68e-05	0.00137	CbGpPWpGaD
Telaprevir—CTSS—Immune System—CDH1—uterine cancer	9.68e-05	0.00137	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—HRAS—uterine cancer	9.47e-05	0.00134	CbGpPWpGaD
Telaprevir—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—uterine cancer	9.4e-05	0.00133	CbGpPWpGaD
Telaprevir—CTSK—Immune System—CDKN1B—uterine cancer	9.18e-05	0.0013	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—KRAS—uterine cancer	9.18e-05	0.0013	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—HRAS—uterine cancer	9.1e-05	0.00128	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	9.07e-05	0.00128	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—KRAS—uterine cancer	8.81e-05	0.00124	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—VEGFA—uterine cancer	8.73e-05	0.00123	CbGpPWpGaD
Telaprevir—ALB—Folate Metabolism—TP53—uterine cancer	8.7e-05	0.00123	CbGpPWpGaD
Telaprevir—CTSK—Immune System—CTNNB1—uterine cancer	8.67e-05	0.00122	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—CCL2—uterine cancer	8.63e-05	0.00122	CbGpPWpGaD
Telaprevir—CTSK—Immune System—PTEN—uterine cancer	8.45e-05	0.00119	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—PIK3CA—uterine cancer	8.43e-05	0.00119	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—AKT1—uterine cancer	8.37e-05	0.00118	CbGpPWpGaD
Telaprevir—CTSS—Immune System—ERBB2—uterine cancer	8.16e-05	0.00115	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—PIK3CA—uterine cancer	8.1e-05	0.00114	CbGpPWpGaD
Telaprevir—CTSK—Immune System—EP300—uterine cancer	8.06e-05	0.00114	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—AKT1—uterine cancer	8.03e-05	0.00113	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—HRAS—uterine cancer	7.8e-05	0.0011	CbGpPWpGaD
Telaprevir—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	7.65e-05	0.00108	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—IRF1—uterine cancer	7.63e-05	0.00108	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	7.62e-05	0.00108	CbGpPWpGaD
Telaprevir—ALB—Metabolism—SRD5A2—uterine cancer	7.61e-05	0.00107	CbGpPWpGaD
Telaprevir—ALB—Metabolism—NDUFB11—uterine cancer	7.61e-05	0.00107	CbGpPWpGaD
Telaprevir—CTSS—Immune System—CDKN1B—uterine cancer	7.56e-05	0.00107	CbGpPWpGaD
Telaprevir—CTSK—Immune System—NRAS—uterine cancer	7.54e-05	0.00106	CbGpPWpGaD
Telaprevir—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	7.54e-05	0.00106	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—HRAS—uterine cancer	7.49e-05	0.00106	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	7.39e-05	0.00104	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—ERBB2—uterine cancer	7.19e-05	0.00101	CbGpPWpGaD
Telaprevir—CTSS—Immune System—CTNNB1—uterine cancer	7.14e-05	0.00101	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	6.98e-05	0.000985	CbGpPWpGaD
Telaprevir—CTSS—Immune System—PTEN—uterine cancer	6.96e-05	0.000982	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—AKT1—uterine cancer	6.89e-05	0.000972	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—CXCL8—uterine cancer	6.82e-05	0.000962	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—NDUFB11—uterine cancer	6.67e-05	0.000941	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—SRD5A2—uterine cancer	6.67e-05	0.000941	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—CDKN1B—uterine cancer	6.66e-05	0.00094	CbGpPWpGaD
Telaprevir—CTSS—Immune System—EP300—uterine cancer	6.64e-05	0.000937	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—AKT1—uterine cancer	6.62e-05	0.000933	CbGpPWpGaD
Telaprevir—CTSK—Immune System—KRAS—uterine cancer	6.49e-05	0.000916	CbGpPWpGaD
Telaprevir—ABCB1—HIF-1-alpha transcription factor network—AKT1—uterine cancer	6.43e-05	0.000908	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—CTNNB1—uterine cancer	6.29e-05	0.000888	CbGpPWpGaD
Telaprevir—CTSS—Immune System—NRAS—uterine cancer	6.21e-05	0.000876	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—PTEN—uterine cancer	6.13e-05	0.000865	CbGpPWpGaD
Telaprevir—CTSK—Immune System—PIK3CA—uterine cancer	5.96e-05	0.000842	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—EP300—uterine cancer	5.85e-05	0.000825	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	5.6e-05	0.00079	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—VEGFA—uterine cancer	5.54e-05	0.000782	CbGpPWpGaD
Telaprevir—CTSK—Immune System—HRAS—uterine cancer	5.52e-05	0.000779	CbGpPWpGaD
Telaprevir—ALB—Metabolism—AKR1B1—uterine cancer	5.5e-05	0.000776	CbGpPWpGaD
Telaprevir—ALB—Metabolism—STAR—uterine cancer	5.5e-05	0.000776	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—NRAS—uterine cancer	5.47e-05	0.000772	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	5.44e-05	0.000768	CbGpPWpGaD
Telaprevir—CTSS—Immune System—KRAS—uterine cancer	5.35e-05	0.000754	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	5.18e-05	0.000731	CbGpPWpGaD
Telaprevir—CTSS—Immune System—PIK3CA—uterine cancer	4.91e-05	0.000693	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	4.9e-05	0.000691	CbGpPWpGaD
Telaprevir—CTSK—Immune System—AKT1—uterine cancer	4.87e-05	0.000688	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—STAR—uterine cancer	4.82e-05	0.00068	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—AKR1B1—uterine cancer	4.82e-05	0.00068	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	4.77e-05	0.000673	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—KRAS—uterine cancer	4.71e-05	0.000664	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	4.55e-05	0.000642	CbGpPWpGaD
Telaprevir—CTSS—Immune System—HRAS—uterine cancer	4.54e-05	0.000641	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—VEGFA—uterine cancer	4.38e-05	0.000618	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—PIK3CA—uterine cancer	4.33e-05	0.00061	CbGpPWpGaD
Telaprevir—ALB—Metabolism—POLD1—uterine cancer	4.32e-05	0.000609	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	4.31e-05	0.000608	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—TP53—uterine cancer	4.19e-05	0.000591	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—NDUFB11—uterine cancer	4.11e-05	0.00058	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—SRD5A2—uterine cancer	4.11e-05	0.00058	CbGpPWpGaD
Telaprevir—ALB—Metabolism—AKR1C1—uterine cancer	4.04e-05	0.00057	CbGpPWpGaD
Telaprevir—CTSS—Immune System—AKT1—uterine cancer	4.01e-05	0.000566	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—HRAS—uterine cancer	4e-05	0.000565	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—POLD1—uterine cancer	3.78e-05	0.000534	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	3.66e-05	0.000517	CbGpPWpGaD
Telaprevir—ALB—Metabolism—RRM2—uterine cancer	3.6e-05	0.000508	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—AKR1C1—uterine cancer	3.54e-05	0.000499	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—AKT1—uterine cancer	3.53e-05	0.000499	CbGpPWpGaD
Telaprevir—ALB—Metabolism—DCN—uterine cancer	3.49e-05	0.000493	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—PIK3CA—uterine cancer	3.42e-05	0.000482	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	3.37e-05	0.000475	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CYP11A1—uterine cancer	3.29e-05	0.000465	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	3.26e-05	0.000459	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—RRM2—uterine cancer	3.15e-05	0.000445	CbGpPWpGaD
Telaprevir—ALB—Metabolism—AKR1C3—uterine cancer	3.11e-05	0.000439	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—DCN—uterine cancer	3.06e-05	0.000432	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—AKR1B1—uterine cancer	2.97e-05	0.000419	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—STAR—uterine cancer	2.97e-05	0.000419	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CYP11A1—uterine cancer	2.89e-05	0.000407	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—AKT1—uterine cancer	2.79e-05	0.000394	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	2.75e-05	0.000388	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—AKR1C3—uterine cancer	2.72e-05	0.000384	CbGpPWpGaD
Telaprevir—ALB—Metabolism—STK11—uterine cancer	2.42e-05	0.000342	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CYP19A1—uterine cancer	2.42e-05	0.000342	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—EP300—uterine cancer	2.38e-05	0.000336	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—POLD1—uterine cancer	2.33e-05	0.000329	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.27e-05	0.000321	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—VEGFA—uterine cancer	2.26e-05	0.000318	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—NRAS—uterine cancer	2.23e-05	0.000314	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—AKR1C1—uterine cancer	2.18e-05	0.000308	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.17e-05	0.000306	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—STK11—uterine cancer	2.12e-05	0.000299	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CYP19A1—uterine cancer	2.12e-05	0.000299	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—RRM2—uterine cancer	1.94e-05	0.000274	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—KRAS—uterine cancer	1.92e-05	0.000271	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—DCN—uterine cancer	1.89e-05	0.000266	CbGpPWpGaD
Telaprevir—ALB—Metabolism—MTHFR—uterine cancer	1.82e-05	0.000257	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CYP11A1—uterine cancer	1.78e-05	0.000251	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—PIK3CA—uterine cancer	1.76e-05	0.000249	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—TP53—uterine cancer	1.7e-05	0.000241	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—AKR1C3—uterine cancer	1.68e-05	0.000237	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—HRAS—uterine cancer	1.63e-05	0.00023	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.6e-05	0.000226	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—MTHFR—uterine cancer	1.6e-05	0.000225	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—AKT1—uterine cancer	1.44e-05	0.000203	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CYP19A1—uterine cancer	1.31e-05	0.000185	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—STK11—uterine cancer	1.31e-05	0.000185	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PTEN—uterine cancer	1.01e-05	0.000143	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—MTHFR—uterine cancer	9.83e-06	0.000139	CbGpPWpGaD
Telaprevir—ALB—Metabolism—EP300—uterine cancer	9.66e-06	0.000136	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PTEN—uterine cancer	8.87e-06	0.000125	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—EP300—uterine cancer	8.46e-06	0.000119	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PIK3CA—uterine cancer	7.14e-06	0.000101	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PIK3CA—uterine cancer	6.26e-06	8.83e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—AKT1—uterine cancer	5.84e-06	8.24e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PTEN—uterine cancer	5.47e-06	7.71e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—EP300—uterine cancer	5.21e-06	7.36e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—AKT1—uterine cancer	5.11e-06	7.22e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PIK3CA—uterine cancer	3.86e-06	5.44e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—AKT1—uterine cancer	3.15e-06	4.45e-05	CbGpPWpGaD
